Atara Biotherapeutics, Inc. (ATRA)
NASDAQ: ATRA · Real-Time Price · USD
4.760
-0.230 (-4.61%)
At close: Apr 28, 2026, 4:00 PM EDT
4.730
-0.030 (-0.63%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Atara Biotherapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 39 | 130 | 77 | 52 | 311 | 1,393 | |
| Market Cap Growth | 25.17% | 70.14% | 46.68% | -83.20% | -77.67% | -14.29% | |
| Enterprise Value | 43 | 134 | 59 | 12 | 122 | 1,061 | |
| Last Close Price | 4.99 | 18.09 | 13.31 | 12.82 | 82.00 | 394.00 | |
| PE Ratio | 1.85 | 3.99 | - | - | - | - | |
| Forward PE | - | 19.88 | - | - | - | - | |
| PS Ratio | 0.34 | 1.08 | 0.60 | 6.10 | 4.89 | 68.51 | |
| PB Ratio | - | -3.39 | -0.79 | -0.53 | 2.46 | 4.98 | |
| P/TBV Ratio | - | - | - | - | 2.46 | 4.98 | |
| EV/Sales Ratio | 0.35 | 1.11 | 0.46 | 1.36 | 1.93 | 52.15 | |
| EV/EBITDA Ratio | 0.83 | 2.59 | - | - | - | - | |
| EV/EBIT Ratio | 0.86 | 2.70 | - | - | - | - | |
| Debt / Equity Ratio | -0.27 | -0.27 | -0.45 | -0.58 | 0.57 | 0.10 | |
| Debt / EBITDA Ratio | 0.18 | 0.18 | - | - | - | - | |
| Net Debt / Equity Ratio | -0.05 | -0.05 | -0.01 | -0.06 | -1.35 | -1.23 | |
| Net Debt / EBITDA Ratio | 0.04 | 0.04 | -0.02 | -0.02 | 0.64 | 1.03 | |
| Net Debt / FCF Ratio | -0.04 | -0.04 | -0.02 | -0.03 | 0.62 | 1.48 | |
| Asset Turnover | 1.87 | 1.87 | 0.94 | 0.03 | 0.15 | 0.04 | |
| Inventory Turnover | - | - | 15.25 | 40.39 | - | - | |
| Quick Ratio | 0.65 | 0.65 | 0.33 | 0.60 | 3.60 | 3.53 | |
| Current Ratio | 0.82 | 0.82 | 0.48 | 0.72 | 3.74 | 3.64 | |
| Return on Equity (ROE) | - | - | - | -2014.86% | -112.39% | -91.69% | |
| Return on Assets (ROA) | 47.81% | 47.81% | -35.66% | -62.11% | -40.63% | -40.29% | |
| Return on Capital Employed (ROCE) | 931.10% | 931.10% | 307.50% | -1156.80% | -92.30% | -94.00% | |
| Earnings Yield | 80.10% | 25.06% | -111.40% | -528.31% | -73.36% | -24.41% | |
| FCF Yield | -124.83% | -39.05% | -89.96% | -371.56% | -88.25% | -16.59% | |
| Buyback Yield / Dilution | -69.84% | -69.84% | -76.77% | -3.83% | -8.88% | -26.63% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.